Ault Milton C III

Director, 10% OwnerAlzamend Neuro, Inc. (ALZN) · full profile →Form 4 · filed Mar 25, 2025
Net Buying
Open-Market Buys
$3K
Open-Market Sells
$0
Net Open-Market Flow
$3K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 21, 2025Buy(P)3K$1.02$3K85K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-25-004752) within minutes of acceptance. Every field above traces to the original document. Verify it directly: